Skip to main content
logo
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.18
+0.31 (1.56%)
Feb 3, 2026, 2:54 PM HKT

HKG:2196 Revenue

Shanghai Fosun Pharmaceutical (Group) had revenue of 9.88B CNY in the quarter ending September 30, 2025, a decrease of -5.46%. This brings the company's revenue in the last twelve months to 39.55B, down -4.96% year-over-year. In the year 2024, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.07B, down -0.80%.

Revenue (ttm)
39.55B CNY
Revenue Growth
-4.96%
P/S Ratio
1.68
Revenue / Employee
982.97K CNY
Employees
40,234
Market Cap
72.68B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.07B-332.34M-0.80%
Dec 31, 202341.40B-2.55B-5.81%
Dec 31, 202243.95B4.94B12.66%
Dec 31, 202139.01B8.70B28.72%
Dec 31, 202030.31B1.72B6.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
China Resources Pharmaceutical Group285.94B
The United Laboratories International Holdings15.45B
Hansoh Pharmaceutical Group Company14.45B
Grand Pharmaceutical Group11.70B
China Medical System Holdings8.61B
Simcere Pharmaceutical Group7.79B
Sunshine Lake Pharma3.96B
Consun Pharmaceutical Group3.58B
Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

More News